Close Menu
    Facebook X (Twitter) Instagram
    SciTechDaily
    • Biology
    • Chemistry
    • Earth
    • Health
    • Physics
    • Science
    • Space
    • Technology
    Facebook X (Twitter) Pinterest YouTube RSS
    SciTechDaily
    Home»Health»New COVID-19 Biomarker Discovery – Can Predict Patient Death or Hospitalization
    Health

    New COVID-19 Biomarker Discovery – Can Predict Patient Death or Hospitalization

    By University of CopenhagenOctober 24, 20216 Comments5 Mins Read
    Facebook Twitter Pinterest Telegram LinkedIn WhatsApp Email Reddit
    Share
    Facebook Twitter LinkedIn Pinterest Telegram Email Reddit
    Research Laboratory COVID Virus
    A new study suggests that analyzing a specific cell surface protein may predict those at risk of severe COVID-19 infection.

    In a new study, researchers from University of Copenhagen show that the phenomenon of cell fitness could predict the host’s immune response to a COVID-19 infection. The discovery could prove to be important for pandemic management.

    As parts of the Western world are slowly returning to normal, many countries in the low- and middle-income countries are still fighting and fearing new outbreaks of COVID-19. And for most it feels almost unbearable to endure another new wave of the virus, which could end in more deaths and long-term persistent symptoms from COVID-19 infection.

    In a new study, researchers from University of Copenhagen present what could be a much-needed helping hand to fight the virus. The study shows that analysis of a particular protein on the cell surface is likely to predict who is in danger of a serious infection caused by the virus, explains Assistant Professor Rajan Gogna, lead author of the new study.

    “Cells have a so-called fitness status, and by analyzing it we could predict hospitalization or death in COVID-19 patients, potentially making such a biomarker an earlier prediction tool, especially because it can be detected from the common nasal swab COVID-19 tests,” says Rajan Gogna from the Won Group at the Biotech Research & Innovation Centre.

    If the cell fitness status is poor, it indicates that the cell does not develop well, either because the cell is aged, lacks reliability, has an ill-functioning metabolism, or is disease-prone, etc. Earlier in 2021, the research team discovered that fitness status is expressed in proteins called flower proteins. These flower proteins are on the surface of the cell, and they are expressed in two forms, explains Rajan Gogna.

    “In one form, they tell the surrounding cells that this cell is doing well. In the other form, they indicate to the surrounding tissue, that this particular cell is not doing well and thus has a bad fitness status. If the cell’s fitness status is not great, the cell will get phased out and killed by the surrounding cells.”

    Accurate Prediction of Serious Infection

    Especially helpful in cases of the early phase of COVID-19 illness, the flower protein expression could accurately predict hospitalization or death as well as predict who would have a less serious infection.

    “The method could predict who needed hospitalization with an accuracy of 78.7 percent. With COVID-19 patients who would not have a serious infection, the prediction was accurate at 93.9 percent,” says Associate Professor and Group Leader Kyoung Jae Won, who analyzed the data using machine learning.

    In order to analyze the data, the researchers performed a post-mortem examination of the infected lung tissue in deceased COVID-19 patients to determine the flower proteins’ biological role in acute lung injury, which is the main cause of death from the disease.

    By using nasal swab samples, they also performed an observational study to evaluate whether the protein expression could accurately predict hospitalization or death.

    “The cell fitness, expressed by the flower protein, could help explain why some people respond poorly to COVID-19 and provide opportunity for pre-identification of high-risk individuals. This discovery has the potential to help save their lives by severely alerting them to be extra protective of themselves, or until they are fortunate enough to get their hands on a vaccine. In some other nations, the population in general has great hesitancy against vaccination. But people are not hesitant about a test, and we hope this will improve outcomes,” says Rajan Gogna.

    Cell Fitness Is Not Just About Your Age

    Cell fitness is relative to many things in our bodies and does not necessarily alter with age. Age has an impact, but the researchers have seen many cases from their database where people who are 80 years of age have a very good fitness profile of lungs, which is the main area where cell fitness is measured to predict COVID-19 infection outcome, explains Rajan Gogna.

    “We have also seen young people die in countries like India, Indonesia, and Brazil. Because it is not only age but the comorbidities which has an impact on the fitness level of the cell in both the upper and lower respiratory tract. Also the insulin signaling, diabetes, and hypertension are known to play a role in determining the cell fitness,” says Rajan Gogna.

    The researchers hope their discovery is timely, because of the persistency of COVID-19 and rising cases and deaths in various nations outside the Western world despite vaccines.

    “In many countries, the populations need protection from the worst outcomes. We believe that these places could benefit from our discovery,” says Rajan Gogna.

    Reference: “Flower lose, a cell fitness marker, predicts COVID-19 prognosis” by Michail Yekelchyk, Esha Madan, Jochen Wilhelm, Kirsty R Short, António M Palma, Linbu Liao, Denise Camacho, Everlyne Nkadori, Michael T Winters, Emily S Rice, Inês Rolim, Raquel Cruz-Duarte, Christopher J Pelham, Masaki Nagane, Kartik Gupta, Sahil Chaudhary, Thomas Braun, Raghavendra Pillappa, Mark S Parker, Thomas Menter, Matthias Matter, Jasmin Dionne Haslbauer, Markus Tolnay, Kornelia D Galior, Kristina A Matkwoskyj, Stephanie M McGregor, Laura K Muller, Emad A Rakha, Antonio Lopez-Beltran, Ronny Drapkin, Maximilian Ackermann, Paul B Fisher, Steven R Grossman, Andrew K Godwin, Arutha Kulasinghe, Ivan Martinez, Clay B Marsh, Benjamin Tang, Max S Wicha, Kyoung Jae Won, Alexandar Tzankov, Eduardo Moreno and Rajan Gogna, 18 October 2021, EMBO Molecular Medicine.
    DOI: 10.15252/emmm.202013714

    Never miss a breakthrough: Join the SciTechDaily newsletter.
    Follow us on Google and Google News.

    Biomarkers COVID-19 Infectious Diseases Molecular Biology Public Health University of Copenhagen
    Share. Facebook Twitter Pinterest LinkedIn Email Reddit

    Related Articles

    Tracing COVID Back to Origin: Many Variant Strains Were Already Present Before the First Known Cases Identified in China

    Genetic Sequencing Shows Coronavirus Variation Drives Pandemic Surges

    An Antiviral Nasal Spray to Prevent COVID / Coronavirus Transmission

    New COVID-19 Test Targets Three Viral Genes to Increase Reliability – Could Reduce Virus Spread

    Replication Cycle of SARS-CoV-2 in 3D – “We Can Expect the Coronavirus to Become Seasonal”

    Halloween and COVID-19: Scientific Study on the Coronavius Risk of Trick-or-Treating

    New Study Shows SARS-CoV-2 Antibodies Detectable Up to 7 Months After COVID-19 Onset

    Researchers Identify 21 Existing Drugs That Could Treat COVID-19

    Scientists Warn That More Bat Research Is Critical to Preventing Next Pandemic

    6 Comments

    1. Disgusted with our current system on October 24, 2021 12:54 pm

      Great… another expensive test the medical community can get paid for. What about the Vit D level of every dead covid patient which has been shown to be under 40. Also were all of the lung cells tested from Remdesivir fed patients. That would be worth knowing also. People all you need to do is take Vit D, Quercetin, Vit C and Zinc and the virus will have difficulty replicating. And of course the I and H C Q medicine that you can’t mention and have trouble getting. It’s out there if you are persistent. This whole plandemic is not about your health so that is part you have to handle yourself.

      Reply
    2. Just Saying the Quiet Part Out Loud on October 24, 2021 2:53 pm

      I assume the “long-term persistent symptoms from COVID-19 infection” class is a euphemism for permanent “vaccine” damage – the loss of 5% of a person’s immune system weekly?

      Reply
    3. Htos1av on October 25, 2021 4:07 am

      Glad I’ll never take the murder shot.

      Reply
    4. smokefire on October 25, 2021 4:27 am

      Medicare is doing an under the radar study on Vitamin D levels.

      Reply
    5. Greg Green on October 25, 2021 11:08 am

      This is exactly what should’ve been worked on from the very beggginig. By March we knew, via the quarantined ship Diamond Princess, that 80% wouldn’t get the virus, more than 10% would be asymptomatic, that those needing hospitalization would be less than 1% and deaths would be much less than 1%. And this was when people were mistreating the disease as a respiratory disease.

      So almost 99% of the population had nothing or little to worry about. But instead of identifying who was vulnerable we had years of lockdowns and ‘vaccines’ that provide no immunity.

      Reply
      • Greg Green on October 25, 2021 11:08 am

        That’s March of 2020 we knew that over 90% would be unaffected by this. We’ve wasted a year and a half.

        Reply
    Leave A Reply Cancel Reply

    • Facebook
    • Twitter
    • Pinterest
    • YouTube

    Don't Miss a Discovery

    Subscribe for the Latest in Science & Tech!

    Trending News

    New Study Reveals Why Ozempic Works Better for Some People Than Others

    Climate Change Is Altering a Key Greenhouse Gas in a Way Scientists Didn’t Expect

    New Study Suggests Gravitational Waves May Have Created Dark Matter

    Scientists Discover Why the Brain Gets Stuck in Schizophrenia

    Scientists Engineer “Tumor-Eating” Bacteria That Devour Cancer From Within

    Even “Failed” Diets May Deliver Long-Term Health Gains, Study Finds

    NIH Scientists Discover Powerful New Opioid That Relieves Pain Without Dangerous Side Effects

    Collapsing Plasma May Hold the Key to Cosmic Magnetism

    Follow SciTechDaily
    • Facebook
    • Twitter
    • YouTube
    • Pinterest
    • Newsletter
    • RSS
    SciTech News
    • Biology News
    • Chemistry News
    • Earth News
    • Health News
    • Physics News
    • Science News
    • Space News
    • Technology News
    Recent Posts
    • This 15,000-Year-Old Discovery Changes What We Know About Early Human Creativity
    • 35-Million-Year-Old Mystery: Strange Arachnid Discovered Preserved in Amber
    • Revolutionary Gas Turbine Generates Power Without Air Compression
    • Is AI Really Just a Tool? It Could Be Altering How You See Reality
    • JWST Reveals a “Forbidden” Planet With a Baffling Composition
    Copyright © 1998 - 2026 SciTechDaily. All Rights Reserved.
    • Science News
    • About
    • Contact
    • Editorial Board
    • Privacy Policy
    • Terms of Use

    Type above and press Enter to search. Press Esc to cancel.